Skip to content
Bicara Therapeutics Inc. (BCAX) Insider Trading
Home / Companies / BCAX BCA
Bicara Therapeutics Inc. (BCAX) XNAS PHARMACEUTICAL PREPARATIONS Net insider selling (90d)
Latest BCAX Insider Trades
About Bicara Therapeutics Inc. (BCAX) Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors. Its program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, directed monoclonal antibody with a domain that binds to human transforming growth factor beta, or TGF-b. The company's goal is to build a fully integrated, commercial-stage biopharmaceutical company that develops important therapies for people living with cancer, starting with ficerafusp alfa.
Headquarters BOSTON, MA
Employees 103
Listed 2024
Exchange XNAS https://www.bicara.com SEC filings for BCAX on EDGAR
90-Day SEC Filing Activity Form 4 transaction type Transactions Shares Total value Open-market sale 12 108,000 $3.08M Grant or award 10 499,225 Option exercise 13 165,000
BCAX Insider Transactions (Form 4) 97 59 Form 4 filings on record, the earliest from Jun 9, 2025, newest first. Filing history page 1 of 2.
Date Insider Transaction Security Shares Price Value Aug 12, 2026 JL Jennifer Larson - Officer Grant or award Stock Option (Right to Buy) 285,000
Recent BCAX Form 8-K Filings 5
Recent BCAX Form 144 Notices of Proposed Sale 3 A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
Filed Filer Relationship Shares Market value Notice Aug 10, 2026 Mazumdar Claire Officer, Director 10,000 $278K View on EDGAR Aug 10, 2026 Hyep Ivan Officer
BCAX Insider Trading - FAQ
What is the latest insider trade for BCAX? Bicara Therapeutics Inc. (BCAX) had 16 insider filings in the last 90 days, with the most recent on 2026-08-14. The full record for BCAX runs to 59 Form 4 filings, the earliest from 2025-06-09. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying BCAX stock? No insider purchases of BCAX were filed in the last 90 days. 2 purchases are on record for this company.
How many insiders are selling BCAX stock? 12 insider sales of BCAX were filed in the last 90 days, totaling $3.08M.
Where can I see BCAX SEC filings (Form 4, 10-K, 10-Q, 8-K)? This page tracks BCAX Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow BCAX insider buys? Create a free InsiderAlpha account and press Watch on this page to add BCAX to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Related Companies - Recent Insider Activity What is SEC Form 4? The filing insiders must submit within two business days of a trade, and how to read its transaction codes. Track BCAX insider activity as it files Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
Sign up free $280K
Market cap $1.55B
P/E ratio -
Dividend yield -
Average volume 721.4K
52 week high $30.99
52 week low $10.30
Today's high $24.59
Today's low $23.36
Open $24.45
Volume 524.7K
Previous close $24.83
Shares outstanding 66.17M Market cap
$1.55B
103 employees
BCAX Insider Sentiment - Last 90 Days Share of open-market insider dollar volume that was buying versus selling, from SEC Form 4 filings.
0% Buying 100% Selling
0 insider purchases totaling $0 against 12 sales totaling $3.08M.
Most-Active BCAX Insiders - Last 90 Days 10 Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
Aug 10, 2026 IH Ivan Hyep - Officer Option exercise Common Stock 12,500 $3.79 $47K
Aug 10, 2026 IH Ivan Hyep - Officer Open-market sale Common Stock 12,500 $27.97 $350K
Aug 10, 2026 IH Ivan Hyep - Officer Option exercise Stock Option (Right to Buy) 12,500 $0.00 -
Aug 10, 2026 CM Claire Mazumdar - Officer Option exercise Common Stock 10,000 $3.79 $38K
Aug 10, 2026 CM Claire Mazumdar - Officer Open-market sale Common Stock 10,000 $27.98 $280K
Aug 10, 2026 CM Claire Mazumdar - Officer Option exercise Stock Option (Right to Buy) 10,000 $0.00 -
Aug 10, 2026 RC Ryan Cohlhepp - Officer Option exercise Common Stock 18,750 $3.79 $71K
Aug 10, 2026 RC Ryan Cohlhepp - Officer Open-market sale Common Stock 18,750 $27.98 $525K
Aug 10, 2026 RC Ryan Cohlhepp - Officer Option exercise Stock Option (Right to Buy) 18,750 $0.00 -
Jul 28, 2026 JB Jeremy Bender - Director Grant or award Stock Option (Right to Buy) 38,950 $0.00 -
Jul 28, 2026 CO Christy J. Oliger - Director Grant or award Stock Option (Right to Buy) 38,950 $0.00 -
Jul 10, 2026 CM Claire Mazumdar - Officer Option exercise Common Stock 10,000 $3.79 $38K
Jul 10, 2026 CM Claire Mazumdar - Officer Open-market sale Common Stock 9,972 $28.42 $283K
Jul 10, 2026 CM Claire Mazumdar - Officer Open-market sale Common Stock 28 $29.68 $831
Jul 10, 2026 CM Claire Mazumdar - Officer Option exercise Stock Option (Right to Buy) 10,000 $0.00 -
Jul 8, 2026 RC Ryan Cohlhepp - Officer Option exercise Common Stock 18,750 $3.79 $71K
Jul 8, 2026 RC Ryan Cohlhepp - Officer Open-market sale Common Stock 22,833 $28.76 $657K
Jul 8, 2026 RC Ryan Cohlhepp - Officer Open-market sale Common Stock 4,306 $29.80 $128K
Jul 8, 2026 RC Ryan Cohlhepp - Officer Open-market sale Common Stock 1,075 $30.35 $33K
Jul 9, 2026 RC Ryan Cohlhepp - Officer Open-market sale Common Stock 536 $29.00 $16K
Jul 8, 2026 RC Ryan Cohlhepp - Officer Option exercise Stock Option (Right to Buy) 18,750 $0.00 -
Jul 8, 2026 IH Ivan Hyep - Officer Option exercise Common Stock 12,500 $3.79 $47K
Jul 8, 2026 IH Ivan Hyep - Officer Open-market sale Common Stock 22,757 $28.60 $651K
Jul 8, 2026 IH Ivan Hyep - Officer Open-market sale Common Stock 4,413 $29.82 $132K
Jul 8, 2026 IH Ivan Hyep - Officer Open-market sale Common Stock 830 $30.31 $25K
Jul 8, 2026 IH Ivan Hyep - Officer Option exercise Stock Option (Right to Buy) 11,592 $0.00 -
Jul 8, 2026 IH Ivan Hyep - Officer Option exercise Stock Option (Right to Buy) 908 $0.00 -
Jun 9, 2026 CB Christopher Bowden - Director Grant or award Stock Option (Right to Buy) 19,475 $0.00 -
Jun 9, 2026 KH Kate Haviland - Director Grant or award Stock Option (Right to Buy) 19,475 $0.00 -
Jun 9, 2026 KM Kiran Mazumdar-Shaw - Director Grant or award Stock Option (Right to Buy) 19,475 $0.00 -
Jun 9, 2026 SR Scott M. Robertson - Director Grant or award Stock Option (Right to Buy) 19,475 $0.00 -
Jun 9, 2026 MP Michael Powell - Director Grant or award Stock Option (Right to Buy) 19,475 $0.00 -
Jun 9, 2026 JS Jake Simson - Director Grant or award Stock Option (Right to Buy) 19,475 $0.00 -
May 21, 2026 IH Ivan Hyep - Officer Option exercise Common Stock 9,200 $3.79 $35K
May 21, 2026 IH Ivan Hyep - Officer Open-market sale Common Stock 9,200 $20.42 $188K
May 21, 2026 IH Ivan Hyep - Officer Option exercise Stock Option (Right to Buy) 9,200 $0.00 -
May 18, 2026 CM Claire Mazumdar - Officer Option exercise Common Stock 15,000 $3.79 $57K
May 18, 2026 CM Claire Mazumdar - Officer Open-market sale Common Stock 12,022 $19.96 $240K
May 18, 2026 CM Claire Mazumdar - Officer Open-market sale Common Stock 2,978 $20.35 $61K
May 18, 2026 CM Claire Mazumdar - Officer Option exercise Stock Option (Right to Buy) 15,000 $0.00 -
May 15, 2026 RC Ryan Cohlhepp - Officer Option exercise Common Stock 8,000 $3.79 $30K
May 15, 2026 RC Ryan Cohlhepp - Officer Open-market sale Common Stock 8,000 $20.29 $162K
May 15, 2026 RC Ryan Cohlhepp - Officer Open-market sale Common Stock 4,500 $20.29 $91K
May 15, 2026 RC Ryan Cohlhepp - Officer Option exercise Stock Option (Right to Buy) 8,000 $0.00 -
May 8, 2026 WS William Schelman - Officer Grant or award Stock Option (Right to Buy) 85,000 $0.00 -
Apr 27, 2026 DR David Raben - Officer Option exercise Common Stock 5,500 $3.79 $21K
Apr 27, 2026 DR David Raben - Officer Open-market sale Common Stock 5,500 $22.88 $126K
Apr 27, 2026 DR David Raben - Officer Option exercise Stock Option (Right to Buy) 5,500 $0.00 -
Apr 21, 2026 IH Ivan Hyep - Officer Option exercise Common Stock 9,200 $3.79 $35K
Apr 21, 2026 IH Ivan Hyep - Officer Open-market sale Common Stock 9,200 $23.00 $212K
Apr 21, 2026 IH Ivan Hyep - Officer Option exercise Stock Option (Right to Buy) 9,200 $0.00 -
Apr 16, 2026 CM Claire Mazumdar - Officer Option exercise Common Stock 8,226 $4.44 $36K
Apr 16, 2026 CM Claire Mazumdar - Officer Option exercise Common Stock 7,454 $3.79 $28K
Apr 16, 2026 CM Claire Mazumdar - Officer Option exercise Common Stock 7,080 $5.45 $39K
Apr 20, 2026 CM Claire Mazumdar - Officer Option exercise Common Stock 15,000 $3.79 $57K
Apr 20, 2026 CM Claire Mazumdar - Officer Open-market sale Common Stock 15,000 $23.61 $354K
Apr 16, 2026 CM Claire Mazumdar - Officer Option exercise Stock Option (Right to Buy) 8,226 $0.00 -
Apr 16, 2026 CM Claire Mazumdar - Officer Option exercise Stock Option (Right to Buy) 7,454 $0.00 -
Apr 16, 2026 CM Claire Mazumdar - Officer Option exercise Stock Option (Right to Buy) 7,080 $0.00 -
Apr 20, 2026 CM Claire Mazumdar - Officer Option exercise Stock Option (Right to Buy) 15,000 $0.00 -
Apr 15, 2026 RC Ryan Cohlhepp - Officer Option exercise Common Stock 8,000 $3.79 $30K
Apr 15, 2026 RC Ryan Cohlhepp - Officer Open-market sale Common Stock 8,000 $23.01 $184K
Apr 15, 2026 RC Ryan Cohlhepp - Officer Open-market sale Common Stock 4,500 $23.01 $104K
Apr 15, 2026 RC Ryan Cohlhepp - Officer Option exercise Stock Option (Right to Buy) 8,000 $0.00 -
Mar 25, 2026 DR David Raben - Officer Option exercise Common Stock 5,500 $3.79 $21K
Mar 25, 2026 DR David Raben - Officer Open-market sale Common Stock 5,500 $18.95 $104K
Mar 25, 2026 DR David Raben - Officer Option exercise Stock Option (Right to Buy) 5,500 $0.00 -
Mar 23, 2026 IH Ivan Hyep - Officer Option exercise Common Stock 9,200 $3.79 $35K
Mar 23, 2026 IH Ivan Hyep - Officer Open-market sale Common Stock 9,200 $18.52 $170K
Mar 23, 2026 IH Ivan Hyep - Officer Option exercise Stock Option (Right to Buy) 9,200 $0.00 -
Mar 18, 2026 CM Claire Mazumdar - Officer Option exercise Common Stock 6,499 $3.79 $25K
Mar 18, 2026 CM Claire Mazumdar - Officer Open-market sale Common Stock 6,499 $18.84 $122K
Mar 19, 2026 CM Claire Mazumdar - Officer Option exercise Common Stock 6,905 $3.79 $26K
Mar 19, 2026 CM Claire Mazumdar - Officer Open-market sale Common Stock 6,905 $18.78 $130K
Mar 20, 2026 CM Claire Mazumdar - Officer Option exercise Common Stock 1,596 $3.79 $6K
Mar 20, 2026 CM Claire Mazumdar - Officer Open-market sale Common Stock 1,596 $18.95 $30K
Mar 18, 2026 CM Claire Mazumdar - Officer Option exercise Stock Option (Right to Buy) 6,499 $0.00 -
Mar 19, 2026 CM Claire Mazumdar - Officer Option exercise Stock Option (Right to Buy) 6,905 $0.00 -
Mar 20, 2026 CM Claire Mazumdar - Officer Option exercise Stock Option (Right to Buy) 1,596 $0.00 -
Mar 16, 2026 RC Ryan Cohlhepp - Officer Option exercise Common Stock 8,000 $3.79 $30K
Mar 16, 2026 RC Ryan Cohlhepp - Officer Open-market sale Common Stock 8,000 $19.66 $157K
Mar 16, 2026 RC Ryan Cohlhepp - Officer Open-market sale Common Stock 4,500 $19.66 $88K
Mar 16, 2026 RC Ryan Cohlhepp - Officer Option exercise Stock Option (Right to Buy) 8,000 $0.00 -
Mar 9, 2026 CM Claire Mazumdar - Officer Option exercise Common Stock 36,766 $3.79 $139K
Mar 9, 2026 CM Claire Mazumdar - Officer Open-market sale Common Stock 36,766 $19.17 $705K
Mar 9, 2026 CM Claire Mazumdar - Officer Option exercise Stock Option (Right to Buy) 36,766 $0.00 -
Mar 6, 2026 CM Claire Mazumdar - Officer Option exercise Stock Option (Right to Buy) 3,817 $0.00 -
Mar 4, 2026 CM Claire Mazumdar - Officer Option exercise Common Stock 2,631 $3.79 $10K
Mar 4, 2026 CM Claire Mazumdar - Officer Open-market sale Common Stock 2,631 $18.73 $49K
Mar 5, 2026 CM Claire Mazumdar - Officer Option exercise Common Stock 1,786 $3.79 $7K
Mar 5, 2026 CM Claire Mazumdar - Officer Open-market sale Common Stock 1,786 $18.74 $33K
Mar 6, 2026 CM Claire Mazumdar - Officer Option exercise Common Stock 3,817 $3.79 $14K
Mar 6, 2026 CM Claire Mazumdar - Officer Open-market sale Common Stock 3,817 $18.75 $72K
Mar 4, 2026 CM Claire Mazumdar - Officer Option exercise Stock Option (Right to Buy) 2,631 $0.00 -
Mar 5, 2026 CM Claire Mazumdar - Officer Option exercise Stock Option (Right to Buy) 1,786 $0.00 -
Aug 10, 2026 Cohlhepp Ryan Officer, Director 18,750 $522K View on EDGAR
$IONS
IONIS PHARMACEUTICALS INC
Ivan Hyep - OfficerOpen-market sale$350K
